PSYCHEDELIC-ASSISTED THERAPY GLOBAL SUMMIT
SCHEDULE
DAY 1
Indigenous, Eastern, & Western Modes of Knowing: Mind, Consciousness, & Spirit
Anja Loizaga-Velder, PhD • Fleet Maull, PhD • Joe Tafur, MD • Atira Tan • Carlos Tanner • Simon Ruffell, MD
Explore Indigenous, Eastern, and Western Perspectives on mind, consciousness, and spirit on Day One. Anja Loizaga-Velder, PhD, begins the day by examining psychedelic therapies through an intercultural lens, followed by Fleet Maull, PhD, who delves into the integration of psychedelics with neuro-somatic mindfulness. Joe Tafur, MD, discusses the connection between epigenetics and psychedelics. Atira Tan offers cross-cultural insights on healing trauma and plant medicine, while Carlos Tanner explores trauma and transformation through the Ayahuasca tradition. Simon Ruffell, MD, closes the day by discussing Ayahuasca’s role in trauma therapy and mental health.
DAY 2
Research, Rescheduling for Clinical Application & Decriminalization
Rick Doblin, PhD • Matthew Johnson, PhD • Katherine MacLean, PhD • Andrew Penn, MS, PMHNP • Cassandra Vieten, PhD • Rick Strassman, MD • Manesh Girn, PhD
The second day focuses on the clinical application, rescheduling, and decriminalization of psychedelics. Rick Doblin, PhD, initiates our journey with a discussion on rescheduling, research, and the road ahead for psychedelics, followed by Matthew Johnson, PhD, who shares insights on research, policy, and the evolving future of psychedelic medicine. Katherine MacLean, PhD, addresses the intersection of science and soul in navigating life and death with psychedelic support. Andrew Penn, MS, PMHNP, provides real-world insights into the legislation and utilization of psychedelic-assisted therapy, while Cassandra Vieten, PhD, explores expanding compassion and consciousness with psychedelics. The day concludes with Rick Strassman, MD, who bridges science and spirit through the lens of DMT therapy, followed by Manesh Girn, PhD, exploring psychedelic neuroscience and the future of healing.
DAY 3
Therapeutic Applications for Specific Mental Health Challenges & Healing Underlying Traumas
Bessel van der Kolk, MD • DaeEss 1Drea Pennington Wasio, MD • Ronald Siegel, PsyD • Licia Sky • Kwasi Adusei, DNP, PMHNP • Sarah Abedi, MD
On Day Three, we examine therapeutic applications for specific mental health challenges. Bessel van der Kolk, MD, begins the day with an exploration of MDMA-assisted therapy, integrative approaches, and the path to lasting trauma recovery. Next, DaeEss 1Drea Pennington Wasio, MD, leads a session on the transformative convergence of modern science and sacred medicine. Ronald Siegel, PsyD, follows with a discussion on the therapeutic potential of psychedelic-assisted healing. Licia Sky emphasizes the role of attunement and connection in psychedelic-assisted therapy, while Kwasi Adusei, DNP, PMHNP, presents a reimagining of mental health. Sarah Abedi, MD, concludes the day by introducing the multi-faceted therapeutic paradigm of psychedelic-assisted therapy.
DAY 4
Practice: Therapeutic Approaches & Strategies, Dosing & Protocols for Safe Delivery
Gita Vaid, MD • Michael Mithoefer, MD & Annie, BSN • Sunny Strasburg, LMFT • Saj Razvi, MA, LPC • James Fadiman, PhD • Pam Kryskow, MD • Dave Asprey
Day Four delves into the nexus of emerging therapeutic strategies for dosing, and safe delivery. Gita Vaid, MD, begins by exploring the art of safe psychedelic practice, introducing tailored protocols for ketamine-assisted therapy. Michael Mithoefer, MD, and Annie Mithoefer, BSN, follow with an examination of redefining individual and relational healing. Sunny Strasburg, LMFT, connects the holistic enhancements of therapeutic experiences with the Theradelic Approach. Saj Razvi, LPC, dives into the somatic and relational depths of psychedelic therapies, while James Fadiman, PhD, discusses the unique transformational possibilities of microdosing. Pam Kryskow, MD, integrates group therapy, Indigenous wisdom, and personalized psychedelic protocols, and the day ends with Dave Asprey’s insights on biohacking the mitochondria to reprogram consciousness using psychedelics.
DAY 5
Before and After Preparation & Integration for Optimal Treatment Effectiveness
Richard Schwartz, PhD • Rosalind Watts, PhD • Sergio Rodriguez-Castillo, PhD, LMFT • Shannon Myers, MS, CRC, CIMHP • Christopher Germer, PhD • Jemie Sae Koo • Lorna Liana, MBA
Day Five explores the synergy of preparation and integration for treatment. Richard Schwartz, PhD, elucidates how psychedelics and Internal Family Systems unlock innate wisdom, followed by Rosalind Watts, PhD’s, insights into nature, connectedness, and the integration of psychedelic healing. Sergio Rodriguez-Castillo, PhD, LMFT, shares his wisdom on the sacred connection in healing, spiritual growth, and Shannon Myers, MS, CRC, CIMHP, presents on the positive impact of trauma-informed preparation and integration. Christopher Germer, PhD, highlights the role of self-compassion in deepening psychedelic-assisted healing. Jemie Sae Koo delves into healing at the root with a holistic approach to Psychedelic Medicines and Lorna Liana, MBA, concludes the day by discussing rooting preparation and integration in a culturally sensitive context.
DAY 6
Standards, Ethics, & Best Practices for Treatment & Training Therapists
Diana Quinn, ND • Ingmar Gorman, PhD • Katja Cahoon, LCSW, MBA • Daan Keiman, MA • Deran Young, LCSW • Neil Markey
Day Six guides us towards ethics and best practices for treatment and training. Diana Quinn, ND, navigates the complexities of ethics and responsibility in psychedelic-assisted therapy facilitation. Ingmar Gorman, PhD, examines the current and evolving landscape of training and practices, followed by Katja Cahoon, LCSW, MBA, who discusses creating safe, ethical, and empowering healing journeys. Daan Keiman, MA, explores the ethical frontier of psychedelic-assisted therapy with spiritual care, while Deran Young, LCSW, addresses effective and ethical psychedelic-assisted therapy for racial trauma. The day concludes with Neil Markey’s insights on blending science, tradition, and ethics for powerful healing.
DAY 7
Delivery Infrastructure & Business Model - Diversity, Equity, Inclusion, & Accessibility
Jeannie Fontana, MD • Poonacha Machaiah, MBA • Darron T. Smith, PhD • Marcus Capone • Ayize Jama-Everett, MDiv • Tania de Jong, AM
Day Seven takes a deep dive into delivery infrastructure and DEIA. Jeannie Fontana, MD, PhD, begins with a discussion on creating a psychedelic-assisted therapy infrastructure for accessible transformative healthcare. Poonacha Machaiah, MBA, follows with insights on conscious leadership and creating equitable access for a global community. Darron T. Smith, PhD, explores healing trauma with psychedelic-assisted therapy in diverse communities, while Marcus Capone addresses the issue of accessibility of psychedelic therapy for everyone. Ayize Jama-Everett, MDiv, focuses on harm reduction and accessibility in psychedelic spaces. The day concludes with Tania de Jong, AM, who examines how psychedelic advocacy, innovation, and research are reshaping the future of healthcare.
